Viral myocarditis: from experimental models to molecular diagnosis in patients.
about
Inflammatory Cardiomyopathy: A Current View on the Pathophysiology, Diagnosis, and TreatmentUnresolved issues in theories of autoimmune disease using myocarditis as a frameworkRole of viruses and other microbes in the pathogenesis of type 1 diabetes.In vivo T2* weighted MRI visualizes cardiac lesions in murine models of acute and chronic viral myocarditis.Cardiac Gab1 deletion leads to dilated cardiomyopathy associated with mitochondrial damage and cardiomyocyte apoptosisA Novel Murine Model of Parvovirus Associated Dilated Cardiomyopathy Induced by Immunization with VP1-Unique Region of Parvovirus B19.Takotsubo cardiomyopathy and acute infectious diseases: a mini-review of case reports.Management of fulminant myocarditis: a diagnosis in search of its etiology but with therapeutic options.Effect of AMP-activated protein kinase activation on cardiac fibroblast proliferation induced by coxsackievirus B3.Takotsubo Cardiomyopathy and Sepsis.A new monoclonal antibody (Cox mAB 31A2) detects VP1 protein of coxsackievirus B3 with high sensitivity and specificity.Substance P receptor antagonism: a potential novel treatment option for viral-myocarditisTLR3 is required for survival following Coxsackievirus B3 infection by driving T lymphocyte activation and polarization: The role of dendritic cells.The presence of enterovirus, adenovirus, and parvovirus B19 in myocardial tissue samples from autopsies: an evaluation of their frequencies in deceased individuals with myocarditis and in non-inflamed control hearts.CD4+ CD25+ GARP+ regulatory T cells display a compromised suppressive function in patients with dilated cardiomyopathy.Parvovirus B19 Achievements and Challenges
P2860
Q26744257-0A1E00CC-2D5E-48CC-B7D6-3098BE3667BAQ34452486-4BF1E79D-5401-4939-B43F-D9D03E87CEA9Q35115373-89C37E29-2122-4EA7-93C7-C4ACF9075C75Q36298445-E516C0DB-73E9-4C3F-866B-B11681F84ED9Q37179335-FCDA5641-F0BA-4E47-8BCB-A22B9EF838D5Q37366530-62C93920-CB11-4156-A7BF-62BA1DE3584CQ38191762-6AFB4217-80E4-41A3-B847-A01EAE849787Q38203822-8AE74F59-6D35-4EB6-99C9-5DA22EB633C8Q38855358-364A30C5-DDEB-4D54-95BB-34D395F30937Q38865564-34B9D39F-7141-434A-8D9D-35724593A697Q40483810-269F9508-FDBA-42F4-BF60-B69E2CD5FEE8Q41371705-A91EDD43-8759-404A-9CDB-60AEEF8C7DB3Q41925485-6A9A2463-C642-4374-8C5F-35537407D5D1Q42221396-488A636A-9318-469D-92D2-AB718F04ABDEQ48227794-58525BEB-5206-4223-8CB1-64A17BD56F61Q58666387-A12DDABB-56F0-4A58-B66F-E10363CC7A1B
P2860
Viral myocarditis: from experimental models to molecular diagnosis in patients.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Viral myocarditis: from experimental models to molecular diagnosis in patients.
@en
type
label
Viral myocarditis: from experimental models to molecular diagnosis in patients.
@en
prefLabel
Viral myocarditis: from experimental models to molecular diagnosis in patients.
@en
P2860
P1476
Viral myocarditis: from experimental models to molecular diagnosis in patients.
@en
P2093
Karin Klingel
Sabine Pankuweit
P2860
P2888
P304
P356
10.1007/S10741-012-9357-4
P577
2013-11-01T00:00:00Z